This company has been acquired
La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Pardes Biosciences Gestione
Gestione criteri di controllo 1/4
Pardes Biosciences' CEO is Tom Wiggans, appointed in Mar 2022, has a tenure of 1.5 years. total yearly compensation is $5.26M, comprised of 9.9% salary and 90.1% bonuses, including company stock and options. directly owns 0.082% of the company’s shares, worth $107.99K. The average tenure of the management team and the board of directors is 2.7 years and 2.4 years respectively.
Informazioni chiave
Tom Wiggans
Amministratore delegato
US$5.3m
Compenso totale
| Percentuale dello stipendio del CEO | 9.9% |
| Mandato del CEO | 1.5yrs |
| Proprietà del CEO | 0.08% |
| Durata media del management | 2.7yrs |
| Durata media del Consiglio di amministrazione | 2.4yrs |
Aggiornamenti recenti sulla gestione
Recent updates
We're Keeping An Eye On Pardes Biosciences' (NASDAQ:PRDS) Cash Burn Rate
Jul 18
Here's Why We're Watching Pardes Biosciences' (NASDAQ:PRDS) Cash Burn Situation
Jan 20We Think Pardes Biosciences (NASDAQ:PRDS) Needs To Drive Business Growth Carefully
Oct 01Pardes begins phase 2 trial of oral drug PBI-0451 for COVID-19
Sep 13Pardes Biosciences GAAP EPS of -$0.48
Aug 15Pardes Biosciences (NASDAQ:PRDS) Is In A Good Position To Deliver On Growth Plans
Jun 14Pardes Biosciences: Advancing A Viral Protease Inhibitor Platform
Jan 21Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -US$76m |
| Mar 31 2023 | n/a | n/a | -US$93m |
| Dec 31 2022 | US$5m | US$521k | -US$97m |
Compensazione vs Mercato: Tom's total compensation ($USD5.26M) is above average for companies of similar size in the US market ($USD758.93K).
Compensazione vs guadagni: Insufficient data to compare Tom's compensation with company performance.
AMMINISTRATORE DELEGATO
Tom Wiggans (71 yo)
1.5yrs
Mandato
US$5,255,958
Compensazione
Mr. Thomas G. Wiggans, also known as Tom, serves as Independent Director at CymaBay Therapeutics, Inc. since April 2021. He serves as an Executive Chairman of Follica, Inc. since January 2021. He serves as...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Chairman of the Board | 1.5yrs | US$5.26m | 0.082% $ 108.0k | |
| Founder & Director | no data | US$3.52m | 9.35% $ 12.3m | |
| Chief Financial Officer | 2.7yrs | US$1.82m | 0.52% $ 684.2k | |
| General Counsel & Corporate Secretary | 2.7yrs | Nessun dato | 0.35% $ 456.1k |
2.7yrs
Durata media
56.5yo
Età media
Gestione esperta: PRDS's management team is considered experienced (2.7 years average tenure).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Chairman of the Board | 1.5yrs | US$5.26m | 0.082% $ 108.0k | |
| Founder & Director | 3.6yrs | US$3.52m | 9.35% $ 12.3m | |
| Director | 2.7yrs | US$110.69k | Nessun dato | |
| Independent Director | 2.7yrs | US$170.69k | 0.12% $ 152.0k | |
| Independent Director & Member of Scientific Advisory Board | 3.1yrs | US$153.69k | 0.12% $ 152.0k | |
| Independent Director | 2.7yrs | US$163.19k | 2.25% $ 2.9m | |
| Independent Director | less than a year | US$147.00k | 0% $ 0 | |
| Independent Director | 2.2yrs | US$161.19k | 0% $ 0 | |
| Lead Independent Director | less than a year | US$146.94k | 0% $ 0 | |
| Independent Director | 2.2yrs | US$153.69k | 0% $ 0 | |
| Member of Commercial Advisory Board | no data | Nessun dato | Nessun dato |
2.4yrs
Durata media
62.5yo
Età media
Consiglio di amministrazione esperto: PRDS's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.